Logan Capital Management’s West Pharmaceutical WST Stock Holding History

Logan Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6	Closed	-$1.36K	–	577
2025 Q1	$1.36K	Hold	6	–	–	﹤0.01%	497
2024 Q4	$1.99K	Sell	6 -11	-65%	-$3.46K	﹤0.01%	459
2024 Q3	$5.12K	Hold	17	–	–	﹤0.01%	426
2024 Q2	$5.62K	Hold	17	–	–	﹤0.01%	408
2024 Q1	$6.75K	Hold	17	–	–	﹤0.01%	408
2023 Q4	$6.01K	Hold	17	–	–	﹤0.01%	429
2023 Q3	$6.4K	Hold	17	–	–	﹤0.01%	419
2023 Q2	$6.52K	Hold	17	–	–	﹤0.01%	415
2023 Q1	$5.91K	Hold	17	–	–	﹤0.01%	431
2022 Q4	$4.01K	Hold	17	–	–	﹤0.01%	469
2022 Q3	$4K	Sell	17 -9	-35%	-$2.74K	﹤0.01%	458
2022 Q2	$8K	Hold	26	–	–	﹤0.01%	450
2022 Q1	$11K	Hold	26	–	–	﹤0.01%	438
2021 Q4	$12K	Buy	26 +9	+53%	+$3.87K	﹤0.01%	450
2021 Q3	$7K	Hold	17	–	–	﹤0.01%	472
2021 Q2	$6K	Hold	17	–	–	﹤0.01%	476
2021 Q1	$5K	Buy	+17	New	+$4.87K	﹤0.01%	455

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Logan Capital Management's WST Position: Q2 2025 in Review

Logan Capital Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 6 shares — an estimated $1.36K sold.

Logan Capital Management first reported a position in WST in Q1 2021 and held it in 17 quarters. The position peaked at $12K in Q4 2021. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

Logan Capital Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Logan Capital Management sold 6 West Pharmaceutical shares in Q2 2025, an estimated $1.36K.
Logan Capital Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 17 quarters.
Logan Capital Management's West Pharmaceutical position peaked at $12K in Q4 2021.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Logan Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.